Morning Market Movers (DEPO, NPSP, ZNWAW, OREX)

Depomed Inc DEPO shares surged 30.93% to $8.17 at 10:00 am. The Food and Drug Administration (FDA) has approved DEPO's Gralise one-daily tablets for the treatment of post-herpetic neuralgia. NPS Pharmaceuticals Inc NPSP shares advanced 22.08% to $9.29. A Phase 3 trial of NPSP's drug GATTEX found that it reduced parenteral nutrition dependence in patients with adult short bowel syndrome. Zion Oil & Gas Inc ZNWAW jumped 20.76% to $6.69. ZNWAW had $11.68 million in total cash and no debt for the latest quarter. Orexigen Therapeutics Inc OREX climbed 16.95% to $9.73. OREX shares have surged 30.00% over the past 52 weeks, while the S&P 500 index has gained 18.85% in the same period. Read more from Benzinga's Markets.